The trademark BIOCARD was filed by Bio-Diagnostics Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on January 12, 2021, and received undefined oppositions.
Opposition Proceedings
There are undefined Oppositions claimed against trademark.
The first opposition filed on April 11, 2021 by Biocartis on Likelihood of confusion. the opponent was represented by DE CLERCQ & PARTNERS and its proceedings were handled in English The second opposition filed on April 7, 2021 by Access Scientific, LLC on Likelihood of confusion. the opponent was represented by CHARRIER RAPP & LIEBAU PATENTANWÄLTE PARTG MBB and its proceedings were handled in English
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).
Deletion of the representative of the trademark registration was recorded on March 4, 2024. Appointment and Replacement of representative of the trademark registration was recorded on March 7, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Medical diagnostic reagents
Medical diagnostic reagents and assays for testing of body fluids
None of the aforesaid relating to testing for biomarkers to assess the risk of developing Dementia
None of the aforesaid goods being for use in relation to a nucleic acid-based (namely DNA/RNA) test.
The mark was filed in class 10 with following description of goods:
Surgical and medical apparatus and instruments
Surgical and medical test kits
Medical diagnostic test kits
Medical diagnostic tests for the detection, diagnosis monitoring, screening and confirmation of diseases
Testing apparatus for sale in kit form for medical diagnostic purposes
None of the aforesaid goods being vascular access catheters, sheath introducers or dilators
None of the aforesaid goods being for use in relation to a nucleic acid-based (namely DNA/RNA) test.
The mark was filed in class 44 with following description of goods:
Medical testing for diagnostic or treatment purposes
Information, advice and consultancy provided in respect of all the aforesaid services
None of the aforesaid relating to testing for biomarkers to assess the risk of developing Dementia
None of the aforesaid services being for use in relation to a nucleic acid-based (namely DNA/RNA) test.